Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof
US-2026092037-A1 · Apr 2, 2026 · US
Glutaric acid
Glutaric acid · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C55/12 |
| Official title | Glutaric acid |
| Display label | Glutaric acid |
| Total patents | 30 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Novel salt forms of isochroman-imidazole structured alpha-2a adrenoceptor agonist
US-2025136583-A1 · May 1, 2025 · US
Crystalline forms of a cdk9 inhibitor and uses thereof
US-2025011298-A1 · Jan 9, 2025 · US
Salt and crystal forms of an epidermal growth factor receptor inhibitor
US-2024293404-A1 · Sep 5, 2024 · US
Processes for preparing aldaric, aldonic, and uronic acids
US-2023002301-A1 · Jan 5, 2023 · US
Solid forms of apol1 inhibitor and methods of using same
US-2021246121-A1 · Aug 12, 2021 · US
Acid addition salts of apomorphine, pharmaceutical compositions containing the same, and methods of using the same
US-2021179561-A1 · Jun 17, 2021 · US
Polymorphic forms and co-crystals of a c-Met inhibitor
US-10344041-B2 · Jul 9, 2019 · US
Cocrystalline DHEA formulations
US-10130713-B2 · Nov 20, 2018 · US
Polymorphic forms and co-crystals of a c-met inhibitor
US-2018244696-A1 · Aug 30, 2018 · US
Preparation method of organic zinc catalyst and poly(alkylene carbonate) resin
US-10047032-B2 · Aug 14, 2018 · US
Polymorphic forms and co-crystals of a c-Met inhibitor
US-9981988-B2 · May 29, 2018 · US
Salts of dasatinib in amorphous form
US-9884857-B2 · Feb 6, 2018 · US
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
US-9676793-B2 · Jun 13, 2017 · US
Photoresist with top-coating photo-decomposable base for photolithography
US-9645499-B2 · May 9, 2017 · US
Preparation method of carboxylic acids or ketones using ozone, singlet state-oxygen atom or hydroxyl free radical
US-9637438-B2 · May 2, 2017 · US
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine
US-2017037006-A1 · Feb 9, 2017 · US
Polymorphic forms and co-crystals of a c-met inhibitor
US-2017029443-A1 · Feb 2, 2017 · US
Process for preparing diacid compounds
US-9382182-B2 · Jul 5, 2016 · US
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2h)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
US-2016176899-A1 · Jun 23, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C55/12?
- CPC C07C55/12 is the Cooperative Patent Classification code for “Glutaric acid.”
- How many patents are filed under CPC C07C55/12 (Glutaric acid)?
- Our database includes 30 publications tagged with this CPC code.
- Is patent activity under CPC C07C55/12 growing?
- Publication counts under this code: 1 in 2024 vs 2 in 2025 (latest complete years).